GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
201 hedge funds and large institutions have $3.07B invested in Global Blood Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 75 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
16% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 75
Holders
201
Holding in Top 10
10
Calls
$83.1M
Puts
$30.2M
Top Buyers
| 1 | +$31.8M | |
| 2 | +$24.4M | |
| 3 | +$17.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$11.1M |
Top Sellers
| 1 | -$23.8M | |
| 2 | -$23.8M | |
| 3 | -$11.2M | |
| 4 |
TA
Teachers Advisors
New York
|
-$10.8M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.56M |